GOLDEN, Colo., March 20, 2012 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, has recently received approval for its presentation entitled “GMP Cell Culture Media for Expansion of MSCS Prior to Allogeneic or Autologous Transplantation.” The Company recently expanded its stem cell media products to include clinical grade MSC-Gro™ media for use in clinical trials of stem cells. The Company will present its current findings at the annual meeting of the International Society of Cellular Therapy (ISCT) in Seattle, Washington this coming June. To get more information regarding the International Society of Cellular Therapy visit http://www.celltherapysociety.org/
